New dehydroabietic acid (DHA) derivatives with anticancer activity against HepG2 cancer cell lines as a potential drug targeting EGFR kinase domain. CoMFA study and virtual ligand-based screening.
作者:
主题词
药物释放系统(Drug Delivery Systems);癌症早期检测(Early Detection of Cancer);Hep G2细胞(Hep G2 Cells);人类(Humans);配体(Ligands);肿瘤(Neoplasms);量化构效关系(Quantitative Structure-Activity Relationship)
DOI
10.1080/07391102.2020.1759452
PMID
32319344
发布时间
2022-05-31
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文